{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:18:39Z","timestamp":1793726319359,"version":"4.6.1"},"reference-count":44,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Next Generation EU-MUR PNRR Extended Partnership Initiative on Emerging Infectious Diseases","award":["PE00000007"],"award-info":[{"award-number":["PE00000007"]}]},{"name":"Next Generation EU-MUR PNRR Extended Partnership Initiative on Emerging Infectious Diseases","award":["PE0000013-FAIR"],"award-info":[{"award-number":["PE0000013-FAIR"]}]},{"name":"PNRR MUR project","award":["PE00000007"],"award-info":[{"award-number":["PE00000007"]}]},{"name":"PNRR MUR project","award":["PE0000013-FAIR"],"award-info":[{"award-number":["PE0000013-FAIR"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: Suppression of Tumorigenicity 2 (ST2), a member of the interleukin-1 receptor family, plays a crucial role in immune regulation. Elevated sST2 levels are associated with poor prognosis in various inflammatory and cardiovascular diseases, including acute heart failure (AHF), sepsis and transplant rejection. Objectives and methods: This study aimed to evaluate the diagnostic and prognostic accuracy of sST2, along with other biomarkers, such as high-sensitivity C-reactive protein (hs-CRP), N-terminal pro-B-type natriuretic peptide (NT-proBNP), procalcitonin (PCT) and mid-regional pro-adrenomedullin (MR-proADM), in patients with AHF, sepsis and AHF\/sepsis overlap. Results: A cohort of 74 patients was analyzed, and comparison statistics revealed that sST2 levels were significantly higher in the AHF\/sepsis group (113.88 ng\/mL) compared to the AHF group (42.24 ng\/mL, p = 0.024), while no significant difference was observed between sepsis and AHF groups (p = 0.10). Other biomarkers, including hs-CRP and PCT, showed significant differences between the AHF and AHF\/sepsis groups. ROC curve analysis identified sST2 as a strong predictor of mortality and readmission, with high AUC values for 30-day readmission (0.821) and mortality (0.87). Conclusions: These findings suggest that combining biomarkers, including sST2, could improve the early diagnosis, risk stratification and management of critically ill patients with overlapping AHF and sepsis. Further studies with larger populations are needed to validate these findings and explore the potential of integrating these biomarkers into clinical practice.<\/jats:p>","DOI":"10.3390\/diagnostics15081010","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T04:05:31Z","timestamp":1744776331000},"page":"1010","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Soluble Suppression of Tumorigenicity 2 (sST2) as a Diagnostic and Prognostic Marker in Acute Heart Failure and Sepsis: A Comparative Analysis"],"prefix":"10.3390","volume":"15","author":[{"given":"Flavio","family":"Davini","sequence":"first","affiliation":[{"name":"Research Unit of Clinical Laboratory Science, Department of Medicine and Surgery, Universit\u00e0 Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21, 00128 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0218-5884","authenticated-orcid":false,"given":"Marta","family":"Fogolari","sequence":"additional","affiliation":[{"name":"Operative Research Unit of Laboratory, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"D\u2019Avanzo","sequence":"additional","affiliation":[{"name":"Diagnostic and Therapeutic Medicine Departement, Fondazione Policlinico Universitario Campus Bio-Medico di Roma, Via Alvaro del Portillo, 200, 00128 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0886-1126","authenticated-orcid":false,"given":"Maria Vittoria","family":"Ristori","sequence":"additional","affiliation":[{"name":"Operative Research Unit of Laboratory, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Nucciarelli","sequence":"additional","affiliation":[{"name":"Research Unit of Clinical Laboratory Science, Department of Medicine and Surgery, Universit\u00e0 Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21, 00128 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucrezia","family":"Bani","sequence":"additional","affiliation":[{"name":"Operative Research Unit of Laboratory, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cristiano","sequence":"additional","affiliation":[{"name":"Operative Research Unit of Laboratory, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"De Cesaris","sequence":"additional","affiliation":[{"name":"Operative Research Unit of Laboratory, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Spoto","sequence":"additional","affiliation":[{"name":"Diagnostic and Therapeutic Medicine Departement, Fondazione Policlinico Universitario Campus Bio-Medico di Roma, Via Alvaro del Portillo, 200, 00128 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Angeletti","sequence":"additional","affiliation":[{"name":"Research Unit of Clinical Laboratory Science, Department of Medicine and Surgery, Universit\u00e0 Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21, 00128 Roma, Italy"},{"name":"Operative Research Unit of Laboratory, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000492885","article-title":"Therapeutic Strategies for Targeting IL-33\/ST2 Signalling for the Treatment of Inflammatory Diseases","volume":"49","author":"Chen","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Zhang, T., Xu, C., Zhao, R., and Cao, Z. (2021). Diagnostic Value of sST2 in Cardiovascular Diseases: A Systematic Review and Meta-Analysis. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.697837"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Sciatti, E., Merlo, A., Scangiuzzi, C., Limonta, R., Gori, M., D\u2019Elia, E., Aimo, A., Vergaro, G., Emdin, M., and Senni, M. (2023). Prognostic Value of sST2 in Heart Failure. J. Clin. Med., 12.","DOI":"10.3390\/jcm12123970"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Wang, Z., Pan, X., Xu, H., Wu, Y., Jia, X., Fang, Y., Lu, Y., Xu, Y., Zhang, J., and Su, Y. (2022). Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.812654"},{"key":"ref_5","first-page":"172","article-title":"Relationship between sST2 Levels and Prognosis in Patients with Pulmonary Arterial Hypertension","volume":"11","author":"Sahin","year":"2020","journal-title":"Ann. Clin. Anal. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ihj.2018.11.014","article-title":"Non-Cardiac Conditions Which Can Elevate The Serum Levels of sST2","volume":"71","author":"Patil","year":"2019","journal-title":"Indian Heart J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2217\/bmm-2020-0410","article-title":"Serum Soluble ST2 as a Novel Biomarker Reflecting Inflammatory Status and Disease Severity in Patients with COVID-19","volume":"14","author":"Zeng","year":"2020","journal-title":"Biomark. Med."},{"key":"ref_8","first-page":"1058","article-title":"Elevated Serum Levels of Soluble ST2 in Severe COVID-19: As a Potential Biomarker for Invasive Mechanical Ventilation","volume":"60","author":"Inoue","year":"2022","journal-title":"Eur. Respir. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"20220639","DOI":"10.1515\/biol-2022-0639","article-title":"Significance of sTREM-1 and sST2 Combined Diagnosis for Sepsis Detection and Prognosis Prediction","volume":"18","author":"Wei","year":"2023","journal-title":"Open Life Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.medcli.2023.04.005","article-title":"Value of Increased Soluble Suppressor Tumorigenicity Biomarker 2 (sST2) on Admission as an Indicator of Severity in Patients with COVID-19","volume":"161","author":"Khan","year":"2023","journal-title":"Med. Clin."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3126\/ajms.v14i11.57756","article-title":"A Study to Determine Systemic Anti-Inflammatory Mediators in Chronic Obstructive Pulmonary Disorder","volume":"14","author":"Sinha","year":"2023","journal-title":"Asian J. Med. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Miftode, R.-S., Constantinescu, D., Cianga, C.M., Petris, A.O., Timpau, A.-S., Crisan, A., Costache, I.-I., Mitu, O., Anton-Paduraru, D.-T., and Miftode, I.-L. (2021). A Novel Paradigm Based on ST2 and Its Contribution towards a Multimarker Approach in the Diagnosis and Prognosis of Heart Failure: A Prospective Study during the Pandemic Storm. Life, 11.","DOI":"10.3390\/life11101080"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"ehae666.979","DOI":"10.1093\/eurheartj\/ehae666.979","article-title":"Association of Soluble ST2 with Heart Failure and Other Comorbidities in Patients with Severe Coronary Heart Disease","volume":"45","author":"Pec","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6258865","DOI":"10.1155\/2021\/6258865","article-title":"A Review of Novel Cardiac Biomarkers in Acute or Chronic Cardiovascular Diseases: The Role of Soluble ST2 (sST2), Lipoprotein-Associated Phospholipase A2 (Lp-PLA2), Myeloperoxidase (MPO), and Procalcitonin (PCT)","volume":"2021","author":"Li","year":"2021","journal-title":"Dis. Markers"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1112.e9","DOI":"10.1016\/j.amjmed.2017.02.034","article-title":"Prognostic Value of Soluble ST2 After Myocardial Infarction: A Community Perspective","volume":"130","author":"Jenkins","year":"2017","journal-title":"Am. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e024417","DOI":"10.1161\/JAHA.121.024417","article-title":"Soluble ST2 Is a Sensitive and Specific Biomarker for Fulminant Myocarditis","volume":"11","author":"Wang","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Lin, W., Fu, C., Miao, J., Hong, W., Chen, X., Yan, S., and Lin, Y. (2024). Association between the Serum Albumin-Creatinine Ratio and 28-Day Intensive Care Unit Mortality among Patients with Sepsis: A Multicenter Retrospective Cohort Study. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1484370"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Dudek, M., Ka\u0142u\u017cna-Oleksy, M., Migaj, J., Sawczak, F., Krysztofiak, H., Lesiak, M., and Straburzy\u0144ska-Migaj, E. (2023). sST2 and Heart Failure-Clinical Utility and Prognosis. J. Clin. Med., 12.","DOI":"10.3390\/jcm12093136"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1473-3099(12)70323-7","article-title":"Procalcitonin as a Diagnostic Marker for Sepsis: A Systematic Review and Meta-Analysis","volume":"13","author":"Wacker","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/CCM.0000000000006241","article-title":"Can Procalcitonin and Other Biomarkers Help Rapidly Identify Sepsis Among Undifferentiated High-Risk Patients in the Emergency Department?","volume":"52","author":"Rhee","year":"2024","journal-title":"Crit. Care Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Doganci, M., Eraslan Doganay, G., Sazak, H., Alag\u00f6z, A., Cirik, M.O., Ho\u015fg\u00fcn, D., Cakiroglu, E.B., Yildiz, M., Ari, M., and Ozdemir, T. (2024). The Utility of C-Reactive Protein, Procalcitonin, and Leukocyte Values in Predicting the Prognosis of Patients with Pneumosepsis and Septic Shock. Medicina, 60.","DOI":"10.20944\/preprints202408.1007.v1"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Singh, A., Singh Patel, S., Sahu, C., Singh, A.K., Tejan, N., Varghese, G., Jamwal, A., Singh, P., and Ghar, M. (2024). Bacterial Profile of Wound Site Infections and Evaluation of Risk Factors for Sepsis among Road Traffic Accident Patients from Apex Trauma Centre, Northern India. Access Microbiol., 6.","DOI":"10.1099\/acmi.0.000836.v4"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/ALN.0000000000000558","article-title":"Ultrasound for \u201cLung Monitoring\u201d of Ventilated Patients","volume":"122","author":"Bouhemad","year":"2015","journal-title":"Anesthesiology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cca.2014.09.021","article-title":"Soluble ST2 in Heart Failure","volume":"443","author":"Dieplinger","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Srdi\u0107, T., \u0110ura\u0161evi\u0107, S., Laki\u0107, I., Ru\u017ei\u010di\u0107, A., Vujovi\u0107, P., Jev\u0111ovi\u0107, T., Daki\u0107, T., \u0110or\u0111evi\u0107, J., Tosti, T., and Glumac, S. (2024). From Molecular Mechanisms to Clinical Therapy: Understanding Sepsis-Induced Multiple Organ Dysfunction. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25147770"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1536\/ihj.52.253","article-title":"Japanese-Western Consensus Meeting on Biomarkers","volume":"52","author":"Maisel","year":"2011","journal-title":"Int. Heart J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/0300060518793791","article-title":"Diagnostic and Predictive Performance of Biomarkers in Patients with Sepsis in an Intensive Care Unit","volume":"47","author":"Zhang","year":"2019","journal-title":"J. Int. Med. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0168-8278(03)00050-3","article-title":"The Effects of Early and Late Administration of Inhibitors of Inducible Nitric Oxide Synthase in a Thioacetamide-Induced Model of Acute Hepatic Failure in the Rat","volume":"38","author":"Rahman","year":"2003","journal-title":"J. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Alcidi, G., Goffredo, G., Correale, M., Brunetti, N.D., and Iacoviello, M. (2022). Brain Natriuretic Peptide Biomarkers in Current Clinical and Therapeutic Scenarios of Heart Failure. J. Clin. Med., 11.","DOI":"10.3390\/jcm11113192"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/ejhf.3036","article-title":"Practical Algorithms for Early Diagnosis of Heart Failure and Heart Stress Using NT-proBNP: A Clinical Consensus Statement from the Heart Failure Association of the ESC","volume":"25","author":"Docherty","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13054-018-2001-5","article-title":"The Use of Mid-Regional Proadrenomedullin to Identify Disease Severity and Treatment Response to Sepsis\u2014A Secondary Analysis of a Large Randomised Controlled Trial","volume":"22","author":"Elke","year":"2018","journal-title":"Crit. Care"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-2796.2010.02287.x","article-title":"Circulating Cardiovascular Biomarkers in Recurrent Atrial Fibrillation: Data from the GISSI-Atrial Fibrillation Trial","volume":"269","author":"Latini","year":"2011","journal-title":"J. Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13054-019-2329-5","article-title":"The Early Identification of Disease Progression in Patients with Suspected Infection Presenting to the Emergency Department: A Multi-Centre Derivation and Validation Study","volume":"23","author":"Saeed","year":"2019","journal-title":"Crit. Care"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","article-title":"Albumin Replacement in Patients with Severe Sepsis or Septic Shock","volume":"370","author":"Caironi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jacc.2017.06.016","article-title":"Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes","volume":"70","author":"Januzzi","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12192-020-01164-3","article-title":"Serum Levels of Anti-Heat Shock Protein 27 Antibodies in Patients with Chronic Liver Disease","volume":"26","author":"Gruden","year":"2021","journal-title":"Cell Stress. Chaperones"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-Reactive Protein Reduction to Cardiovascular Event Reduction Following Treatment with Canakinumab: A Secondary Analysis from the CANTOS Randomised Controlled Trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ahj.2016.10.010","article-title":"Safety Profile and Utility of Treadmill Exercise in Patients with High-Gradient Hypertrophic Cardiomyopathy","volume":"184","author":"Sorensen","year":"2017","journal-title":"Am. Heart J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5114\/ait.2022.115367","article-title":"Mid-Regional pro-Adrenomedullin as a Predictor of in-Hospital Mortality in Adult Patients with COVID-19: A Single-Centre Prospective Study","volume":"54","author":"Popov","year":"2022","journal-title":"Anaesthesiol. Intensive Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.15420\/ecr.2020.49","article-title":"The Role of C-Reactive Protein in Patient Risk Stratification and Treatment","volume":"16","author":"Avanzas","year":"2021","journal-title":"Eur. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-med-042220-022745","article-title":"Heart Failure with Preserved Ejection Fraction: Mechanisms and Treatment Strategies","volume":"73","author":"Omote","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"R6","DOI":"10.1186\/cc13183","article-title":"Presepsin (Soluble CD14 Subtype) and Procalcitonin Levels for Mortality Prediction in Sepsis: Data from the Albumin Italian Outcome Sepsis Trial","volume":"18","author":"Masson","year":"2014","journal-title":"Crit. Care"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1631\/jzus.B2000049","article-title":"Multi-Biomarker Strategy for Prediction of Myocardial Dysfunction and Mortality in Sepsis","volume":"21","author":"Chen","year":"2020","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.clinbiochem.2015.07.031","article-title":"Plasma Concentrations of Novel Cardiac Biomarkers before and after Hemodialysis Session","volume":"48","author":"Mueller","year":"2015","journal-title":"Clin. Biochem."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/8\/1010\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:15:18Z","timestamp":1760030118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/8\/1010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["diagnostics15081010"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15081010","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]}}}